Summary

The global medical plastics market is expected to be valued at USD 34.77 billion in 2026 and USD 48.77 billion by 2031, registering a CAGR of 7.0% during the forecast period. Rising demand for advanced medical devices and single-use healthcare products is driving the market. The mounting demand for safe, lightweight, and efficient polymers for healthcare applications and the growing incidence of chronic diseases among an aging population create market growth opportunities. Furthermore, the increasing use of minimally invasive procedures, combined with the use of disposable medical devices to decrease infection rates, also adds to the momentum of the market.

High-performance plastics segment to record the highest CAGR from 2026 to 2031
In terms of type, the high-performance plastics segment is anticipated to be the fastest-growing in the medical plastics market during the forecast period. The segmental growth is attributed to its remarkable mechanical strength, chemical resistance, excellent thermal stability, and biocompatibility. High-tech materials, including PEEK, PTFE, and PPSU, represent this segment. It is embraced in high-end medical applications looking for high reliability and performance under demanding medical conditions. Orthopedic and spinal implants, surgical instruments, catheter parts, drug delivery systems, dental devices, and tools used in repeated sterilization are among the key applications of these materials due to their low weight, dimensional stability, resistance to wear, and repeated sterilization ability. In addition, they can replace metals in the field while being radiolucent and offering corrosion resistance and design flexibility.

Medical disposables segment to hold the largest share of the medical plastics market in 2031
In terms of application, the medical disposables segment is projected to capture the largest market share in 2031, owing to the extensive usage in hospitals, ambulatory care facilities, diagnostic laboratories, and home healthcare. Various products, including syringes, gloves, IV components, blood collection devices, surgical disposables, specimen containers, and disposable respiratory products, heavily depend on medical-grade plastics to maintain sterility and ensure patient safety at a cost-effective production level. Increasing volumes of surgical procedures, rising measures taken for infection prevention, growing vaccination and diagnostic programs, and increasing popularity of disposable plastic products drive the demand for medical disposables. Moreover, the stringent regulatory framework and the emphasis on the prevention of hospital-acquired infections solidify the market leadership of the segment.

Europe to be the second-largest region in the medical plastics market during the forecast period
In terms of region, Europe is anticipated to hold the second-largest share of the medical plastic market between 2026 and 2031 due to the advanced medical device manufacturing industry, better healthcare infrastructure, and strict regulations governing medical plastic and patient safety. The region houses many prominent manufacturers of medical devices, polymers, and other packaging products for healthcare, hence stimulating innovations in high-performance medical plastics. Increased need for minimally invasive procedures, aging populations, growing prevalence of chronic diseases, and expansion of the pharmaceutical and biotech industry are driving the regional market.

Breakdown of Primary Interviews:
- By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
- By Designation: Directors: 30%, Managers: 20%, and Others: 50%
- By Region: North America: 20%, Europe: 10%, Asia Pacific: 40%, South America: 10%, and Middle East & Africa: 20%
Notes: Others include sales, marketing, and product managers.
Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: <USD 500 million

Companies Covered: BASF (Germany), Celanese Corporation (US), SABIC (Saudi Arabia), Covestro AG (Germany), Syensqo (Belgium), Evonik Industries (Germany), Arkema (France), Lubrizol (US), Ensinger (Germany), and Dow (US), among others, are covered in the report.

The study includes an in-depth competitive analysis of these key players in the medical plastics market, with their company profiles, recent developments, and key market strategies.

Research Coverage
This research report categorizes the medical plastics market based on type (standard plastics, engineering plastics, high-performance plastics, silicone, and other types) and application (medical disposables, medical instruments & devices, prosthetics & implants, drug delivery, medical packaging, and other applications). The report’s scope covers detailed information regarding drivers, restraints, challenges, and opportunities influencing the market growth. A detailed analysis of the key industry players has been done to provide insights into their business overviews, products offered, and key strategies, such as mergers, acquisitions, product launches, and expansions, associated with the medical plastics market. This report covers a competitive analysis of upcoming startups in the medical plastics market ecosystem.

Reasons to Buy the Report
The report will offer the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall medical plastics market and the subsegments. This report will help stakeholders understand the competitive landscape, gain more insights into positioning their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:
- Analysis of key drivers (Rising demand for single-use and disposable medical devices, Growing global aging population and chronic disease burden, Increasing adoption of advanced medical devices and minimally invasive procedures), restraints (Stringent regulatory and material validation requirements, Environmental concerns related to plastic waste), opportunities (Growing adoption of bio-based and sustainable medical plastics, Expanding healthcare infrastructure in emerging economies), and challenges (Issues in balancing sustainability requirements with stringent medical performance standards, Supply chain complexity for high-performance medical-grade polymers)
- Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the medical plastics market
- Market Development: Comprehensive information about profitable markets (the report analyzes the medical plastics market across varied regions)
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical plastics market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as BASF (Germany), Celanese Corporation (US), SABIC (Saudi Arabia), Covestro AG (Germany), Syensqo (Belgium), Evonik Industries (Germany), Arkema (France), Lubrizol (US), Ensinger (Germany), and Dow (US), among others

ページTOPに戻る

Table of Contents

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 27
1.3.2 INCLUSIONS AND EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 29
1.3.4 CURRENCY CONSIDERED 29
1.3.5 UNITS CONSIDERED 29
1.4 STAKEHOLDERS 29
1.5 SUMMARY OF CHANGES 29

2 EXECUTIVE SUMMARY 31
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 31
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 33
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 34
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 35
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 36

3 PREMIUM INSIGHTS 37
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL PLASTICS MARKET 37
3.2 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION AND COUNTRY 38
3.3 MEDICAL PLASTICS MARKET, BY TYPE 39
3.4 MEDICAL PLASTICS MARKET, BY COUNTRY 39

4 MARKET OVERVIEW 40
4.1 INTRODUCTION 40
4.2 MARKET DYNAMICS 41
4.2.1 DRIVERS 41
4.2.1.1 Rising demand for single-use and disposable medical devices 41
4.2.1.2 Growing global aging population and rising chronic disease burden 42
4.2.1.3 Increasing adoption of advanced medical devices and minimally invasive procedures 43
4.2.2 RESTRAINTS 43
4.2.2.1 Stringent regulatory and material validation requirements 43
4.2.2.2 Environmental concerns related to plastic waste 43
4.2.3 OPPORTUNITIES 44
4.2.3.1 Growing adoption of bio-based and sustainable medical plastics 44
4.2.3.2 Expanding healthcare infrastructure in emerging economies 45
4.2.4 CHALLENGES 47
4.2.4.1 Balancing sustainability requirements with stringent medical performance standards 47
4.2.4.2 Supply chain complexity for high-performance medical-grade polymers 47
4.3 UNMET NEEDS AND WHITE SPACES 48
4.3.1 UNMET NEEDS IN MEDICAL PLASTICS MARKET 48
4.3.2 WHITE SPACE OPPORTUNITIES 49
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 50
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 51
4.5.1 KEY MOVES AND STRATEGIC FOCUS 51
4.6 PORTER’S FIVE FORCES ANALYSIS 52
4.6.1 BARGAINING POWER OF SUPPLIERS 53
4.6.2 BARGAINING POWER OF BUYERS 54
4.6.3 THREAT OF SUBSTITUTES 54
4.6.4 THREAT OF NEW ENTRANTS 55
4.6.5 INTENSITY OF COMPETITIVE RIVALRY 56
4.7 VALUE CHAIN ANALYSIS 56
4.7.1 RAW MATERIAL SUPPLIERS 58
4.7.2 DISTRIBUTORS 58
4.7.3 MANUFACTURERS 58
4.7.4 END CONSUMERS 59
4.8 ECOSYSTEM 59
4.9 PRICING ANALYSIS 61
4.9.1 AVERAGE SELLING PRICE TREND, BY REGION 61
4.10 MACROECONOMIC INDICATORS 61
4.10.1 GLOBAL GDP TRENDS 62
4.10.2 HEALTHCARE INDUSTRY TRENDS 63
4.11 IMPACT OF 2025 US TARIFFS ON MEDICAL PLASTICS MARKET 64
4.11.1 INTRODUCTION 64
4.11.2 KEY TARIFF RATES 65
4.11.3 PRICE IMPACT ANALYSIS 65
4.11.4 IMPACT ON COUNTRIES/REGIONS 66
4.11.4.1 US 66
4.11.4.2 Europe 67
4.11.4.3 Asia Pacific 67
4.11.5 IMPACT ON END-USE INDUSTRIES 67
4.12 TRADE ANALYSIS 68
4.12.1 IMPORT SCENARIO (HS CODE 3926) 68
4.12.2 EXPORT SCENARIO (HS CODE 3926) 69
4.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 71
4.14 INVESTMENT AND FUNDING SCENARIO 71
4.15 CASE STUDY ANALYSIS 72
4.15.1 COVESTRO AG INTRODUCES CIRCULAR MEDICAL-GRADE POLYCARBONATE FOR HEALTHCARE APPLICATIONS 72
4.15.2 CELANESE CORPORATION EXPANDS GUR UHMW-PE PORTFOLIO FOR MEDICAL APPLICATIONS 73
4.15.3 EVONIK INDUSTRIES ADVANCES IMPLANTABLE BIOMATERIALS
FOR MEDICAL DEVICES 73
4.16 KEY CONFERENCES & EVENTS 74

5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 75
5.1 TECHNOLOGY ANALYSIS 75
5.1.1 KEY TECHNOLOGIES 75
5.1.1.1 Bio-based and bio-attributed medical-grade polymers 75
5.1.1.2 High-performance polymers for implantable and minimally
invasive devices 76
5.1.1.3 Medical-grade additive manufacturing (3D printing) of polymers 76
5.1.2 COMPLEMENTARY TECHNOLOGIES 76
5.1.2.1 AI-powered quality inspection and smart manufacturing systems 76
5.1.2.2 Digital twin technology for manufacturing process optimization 76
5.2 TECHNOLOGY/PRODUCT ROADMAP 77
5.2.1 SHORT TERM (2025-2027) | MATERIAL INNOVATION & REGULATORY FOUNDATION 77
5.2.2 MID-TERM (2027-2030) | SMART MATERIALS & DIGITAL MANUFACTURING 78
5.2.3 LONG TERM (2030-2030+) | SUSTAINABLE HIGH-PERFORMANCE MATERIALS & AUTONOMOUS MANUFACTURING 78
5.3 PATENT ANALYSIS 79
5.3.1 LEGAL STATUS OF PATENTS 80
5.3.2 JURISDICTION ANALYSIS 80
5.4 FUTURE APPLICATIONS 81
5.4.1 ADVANCED SINGLE-USE MEDICAL DEVICES & INFECTION PREVENTION 82
5.4.2 ADVANCED DRUG DELIVERY & COMBINATION MEDICAL DEVICES 82
5.4.3 BIOPHARMACEUTICAL MANUFACTURING & ADVANCED THERAPIES 83
5.4.4 SMART DIAGNOSTICS, WEARABLE HEALTHCARE & HOME MEDICAL DEVICES 83
5.4.5 ROBOTIC SURGERY, MINIMALLY INVASIVE DEVICES & HIGH-PERFORMANCE MEDICAL COMPONENTS 84
5.5 IMPACT OF AI/GEN AI ON MEDICAL PLASTICS MARKET 84
5.5.1 TOP USE CASES AND MARKET POTENTIAL OF MEDICAL PLASTICS 85
5.5.2 BEST PRACTICES IN MEDICAL PLASTICS PROCESSING 85
5.5.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL PLASTICS MARKET 86
5.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT
ON MARKET PLAYERS 87
5.5.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MEDICAL
PLASTICS MARKET 87

6 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 88
6.1 REGIONAL REGULATIONS AND COMPLIANCE 88
6.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
6.1.2 INDUSTRY STANDARDS 91
6.2 IMPACT OF REGULATORY POLICIES AND SUSTAINABILITY INITIATIVES 92
6.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 93

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 94
7.1 INTRODUCTION 94
7.2 DECISION-MAKING PROCESS 94
7.3 KEY STAKEHOLDERS AND BUYING CRITERIA 96
7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
7.3.2 BUYING CRITERIA 96
7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 97
7.5 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 99
7.6 MARKET PROFITABILITY 100
7.6.1 REVENUE POTENTIAL 101
7.6.2 COST DYNAMICS 101
7.6.3 MARGIN OPPORTUNITIES IN KEY END-USE INDUSTRIES 101

8 MEDICAL PLASTICS MARKET, BY TYPE 103
8.1 INTRODUCTION 104
8.2 POLYPROPYLENE (PP) 107
8.2.1 HIGH FATIGUE RESISTANCE AND STERILIZATION STABILITY
SUPPORTING REUSABLE AND DISPOSABLE DEVICES 107
8.3 POLYVINYL CHLORIDE (PVC) 107
8.3.1 EXCELLENT FLEXIBILITY, STERILIZATION COMPATIBILITY, AND COST EFFICIENCY TO SUPPORT HIGH-VOLUME MEDICAL APPLICATIONS 107
8.4 POLYETHYLENE (PE) 107
8.4.1 OUTSTANDING CHEMICAL RESISTANCE AND BIOCOMPATIBILITY DRIVING DISPOSABLE HEALTHCARE PRODUCTS 107
8.5 POLYSTYRENE (PS) 107
8.5.1 SUPERIOR CLARITY AND DIMENSIONAL PRECISION ENABLING DIAGNOSTIC AND LABORATORY APPLICATIONS 107
8.6 POLYMETHYL METHACRYLATE (PMMA) 108
8.6.1 HIGH OPTICAL TRANSPARENCY AND WEATHER RESISTANCE ADVANCING SPECIALIZED MEDICAL DEVICES 108
8.7 ENGINEERING AND HIGH PERFORMANCE PLASTICS 108
8.7.1 POLYETHER ETHER KETONE (PEEK) 108
8.7.1.1 Superior mechanical performance and biocompatibility accelerating implant innovation 108
8.7.2 POLYAMIDE (PA) 108
8.7.2.1 Excellent mechanical strength and wear resistance supporting precision medical components 108
8.7.3 POLYPHENYLSULFONE (PPSU) 109
8.7.3.1 Excellent sterilization durability and impact resistance supporting reusable medical devices 109
8.7.4 POLYSULFONE (PSU) 109
8.7.4.1 High thermal stability and hydrolytic resistance driving adoption in reusable medical devices 109
8.7.5 POLYCARBONATE (PC) 109
8.7.5.1 Exceptional transparency and impact resistance supporting advanced healthcare devices 109
8.7.6 ACRYLONITRILE BUTADIENE STYRENE (ABS) 109
8.7.6.1 High impact strength and dimensional stability enabling durable medical equipment 109
8.7.7 OTHER ENGINEERING AND HIGH-PERFORMANCE PLASTICS 109
8.8 OTHER TYPES 110

9 MEDICAL PLASTICS MARKET, BY APPLICATION 111
9.1 INTRODUCTION 112
9.2 MEDICAL DISPOSABLES 114
9.2.1 MEDICAL BAGS 114
9.2.1.1 Reliable fluid containment and sterility driving demand in healthcare 114
9.2.2 CATHETERS 114
9.2.2.1 Precision polymer technologies enabling minimally invasive therapies 114
9.2.3 SYRINGES 114
9.2.3.1 High-volume disposable devices supporting safe drug administration 114
9.2.4 OTHER DISPOSABLES 114
9.3 MEDICAL INSTRUMENTS & DEVICES 114
9.3.1 SURGICAL INSTRUMENTS 115
9.3.1.1 Lightweight engineering polymers improving surgical precision 115
9.3.2 DIAGNOSTIC DEVICES 115
9.3.2.1 Precision plastics enabling accurate diagnostic performance 115
9.3.3 DENTAL INSTRUMENTS 115
9.3.3.1 Durable biocompatible polymers advancing dental treatments 115
9.4 PROSTHETICS & IMPLANTS 115
9.4.1 LIMB PROSTHETICS 115
9.4.1.1 Lightweight high-strength polymers enhancing patient mobility 115
9.4.2 IMPLANTS 115
9.4.2.1 Advanced biomaterials improving long-term clinical performance 115
9.5 DRUG DELIVERY 116
9.6 MEDICAL PACKAGING 116
9.7 OTHER APPLICATIONS 116

10 MEDICAL PLASTICS MARKET, BY REGION 117
10.1 INTRODUCTION 118
10.2 NORTH AMERICA 120
10.2.1 US 126
10.2.1.1 FDA regulatory excellence, robust healthcare spending, and advanced medical device manufacturing to drive market 126
10.2.2 CANADA 128
10.2.2.1 Universal healthcare investments, regulatory modernization, and expanding home healthcare services to accelerate growth 128
10.2.3 MEXICO 130
10.2.3.1 Nearshoring investments, export-oriented medical device manufacturing, and regulatory reforms propelling demand 130
10.3 EUROPE 133
10.3.1 GERMANY 138
10.3.1.1 Advanced medical device manufacturing, healthcare reforms, and aging population to fuel demand 138
10.3.2 FRANCE 140
10.3.2.1 Biopharmaceutical innovation, government healthcare investments, and France 2030 Strategy to strengthen market 140
10.3.3 SPAIN 142
10.3.3.1 Strong economic growth, healthcare digitalization, and medical device investments accelerating market growth 142
10.3.4 UK 144
10.3.4.1 NHS investment, regulatory modernization, and life sciences innovation driving growth 144
10.3.5 ITALY 146
10.3.5.1 Mirandola biomedical cluster, healthcare modernization, and medical device manufacturing strength supporting market 146
10.3.6 REST OF EUROPE 148
10.4 ASIA PACIFIC 150
10.4.1 CHINA 156
10.4.1.1 Manufacturing scale, regulatory modernization, and healthcare investments driving market 156
10.4.2 JAPAN 158
10.4.2.1 Aging demographics, rising healthcare expenditure, and stringent regulatory standards to support market growth 158
10.4.3 INDIA 160
10.4.3.1 Production-linked incentives, healthcare infrastructure expansion, and rising domestic manufacturing to propel market 160
10.4.4 SOUTH KOREA 162
10.4.4.1 Government MedTech investments, advanced manufacturing, and digital healthcare expansion driving market 162
10.4.5 REST OF ASIA PACIFIC 164
10.5 MIDDLE EAST & AFRICA 166
10.5.1 GCC COUNTRIES 172
10.5.1.1 Healthcare infrastructure expansion, rising chronic disease burden, and medical technology investments to fuel demand 172
10.5.1.2 Saudi Arabia 173
10.5.1.2.1 Vision 2030 healthcare transformation, medical infrastructure investments, and regulatory modernization to support market growth 173
10.5.1.3 UAE 175
10.5.1.3.1 Healthcare hub development, regulatory transformation, and medical tourism drive market 175
10.5.1.4 Rest of GCC 177
10.5.2 SOUTH AFRICA 179
10.5.2.1 National health insurance reform, expanding healthcare access, and rising chronic disease burden to support market 179
10.5.3 REST OF MIDDLE EAST & AFRICA 181
10.6 SOUTH AMERICA 183
10.6.1 BRAZIL 189
10.6.1.1 Universal healthcare expansion, healthcare infrastructure investments, and regulatory modernization to drive market 189
10.6.2 ARGENTINA 191
10.6.2.1 Macroeconomic stabilization, regulatory modernization, and rising healthcare demand to accelerate market 191
10.6.3 REST OF SOUTH AMERICA 193

11 COMPETITIVE LANDSCAPE 196
11.1 OVERVIEW 196
11.2 KEY PLAYERS' STRATEGIES/RIGHT TO WIN 196
11.3 REVENUE ANALYSIS, 2021–2025 198
11.4 MARKET SHARE ANALYSIS, 2025 199
11.5 PRODUCT COMPARISON 201
11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 203
11.6.1 STARS 203
11.6.2 EMERGING LEADERS 203
11.6.3 PERVASIVE PLAYERS 204
11.6.4 PARTICIPANTS 204
11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 205
11.6.5.1 Company footprint 205
11.6.5.2 Region footprint 205
11.6.5.3 Type footprint 206
11.6.5.4 Application footprint 207
11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 207
11.7.1 PROGRESSIVE COMPANIES 207
11.7.2 RESPONSIVE COMPANIES 207
11.7.3 DYNAMIC COMPANIES 208
11.7.4 STARTING BLOCKS 208
11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 209
11.7.5.1 Detailed list of key startups/SMEs 209
11.7.5.2 Competitive benchmarking of key startups/SMEs 211
11.8 COMPANY VALUATION & FINANCIAL METRICS 212
11.8.1 FINANCIAL METRICS 212
11.8.2 COMPANY VALUATION 213
11.8.3 ENTERPRISE VALUATION 213
11.9 COMPETITIVE SCENARIO 214
11.9.1 PRODUCT LAUNCHES 214
11.9.2 DEALS 215
11.9.3 EXPANSIONS 216

12 COMPANY PROFILES 217
12.1 KEY PLAYERS 217
12.1.1 BASF 217
12.1.1.1 Business overview 217
12.1.1.2 Products/Solutions/Services offered 218
12.1.1.2.1 Recent developments 219
12.1.1.2.2 Expansions 220
12.1.1.3 MnM view 220
12.1.1.3.1 Right to win 220
12.1.1.3.2 Strategic choices 220
12.1.1.3.3 Weaknesses and competitive threats 221
12.1.2 CELANESE CORPORATION 222
12.1.2.1 Business overview 222
12.1.2.2 Products/Solutions/Services offered 223
12.1.2.3 Recent developments 225
12.1.2.3.1 Deals 225
12.1.2.4 MnM view 225
12.1.2.4.1 Right to win 225
12.1.2.4.2 Strategic choices 225
12.1.2.4.3 Weaknesses and competitive threats 226
12.1.3 SABIC 227
12.1.3.1 Business overview 227
12.1.3.2 Products/Solutions/Services offered 228
12.1.3.3 Recent developments 230
12.1.3.3.1 Product launches 230
12.1.3.3.2 Deals 231
12.1.3.4 MnM view 231
12.1.3.4.1 Right to win 231
12.1.3.4.2 Strategic choices 231
12.1.3.4.3 Weaknesses and competitive threats 232
12.1.4 COVESTRO AG 233
12.1.4.1 Business overview 233
12.1.4.2 Products/Solutions/Services offered 234
12.1.4.3 Recent developments 236
12.1.4.3.1 Product launches 236
12.1.4.4 MnM view 236
12.1.4.4.1 Right to win 236
12.1.4.4.2 Strategic choices 236
12.1.4.4.3 Weaknesses and competitive threats 237
12.1.5 SYENSQO 238
12.1.5.1 Business overview 238
12.1.5.2 Products/Solutions/Services offered 239
12.1.5.3 Recent developments 240
12.1.5.3.1 Product launches 240
12.1.5.3.2 Deals 241
12.1.5.4 MnM view 241
12.1.5.4.1 Right to win 241
12.1.5.4.2 Strategic choices 241
12.1.5.4.3 Weaknesses and competitive threats 242
12.1.6 EVONIK INDUSTRIES 243
12.1.6.1 Business overview 243
12.1.6.2 Products/Solutions/Services offered 244
12.1.6.3 Recent developments 245
12.1.6.3.1 Product launches 245
12.1.6.3.2 Expansions 245
12.1.6.4 MnM view 245
12.1.7 ARKEMA 247
12.1.7.1 Business overview 247
12.1.7.2 Products/Solutions/Services offered 248
12.1.7.3 Recent developments 249
12.1.7.3.1 Product launches 249
12.1.7.3.2 Deals 250
12.1.7.4 MnM view 250
12.1.8 LUBRIZOL 251
12.1.8.1 Business overview 251
12.1.8.2 Products/Solutions/Services offered 252
12.1.8.3 Recent developments 254
12.1.8.3.1 Product launches 254
12.1.8.3.2 Deals 254
12.1.8.3.3 Expansions 255
12.1.8.4 MnM view 256
12.1.9 ENSINGER 257
12.1.9.1 Business overview 257
12.1.9.2 Products/Solutions/Services offered 257
12.1.9.3 MnM view 258
12.1.10 DOW 260
12.1.10.1 Business overview 260
12.1.10.2 Products/Solutions/Services offered 261
12.1.10.3 Recent developments 262
12.1.10.3.1 Deals 262
12.1.10.4 MnM view 263
12.2 OTHER PLAYERS 264
12.2.1 TRINSEO 264
12.2.2 BIOMERICS 265
12.2.3 ENVALIOR 266
12.2.4 EASTMAN CHEMICAL COMPANY 267
12.2.5 INVIBIO LTD. 268
12.2.6 LYONDELLBASELL INDUSTRIES HOLDINGS B.V. 269
12.2.7 MITSUBISHI CHEMICAL GROUP 270
12.2.8 AVIENT CORPORATION 271
12.2.9 RÖCHLING SE & CO. KG 272
12.2.10 RTP COMPANY 273
12.2.11 SAINT-GOBAIN 274
12.2.12 TEKNI-PLEX, INC. 275
12.2.13 TEKNOR APEX COMPANY 276
12.2.14 WACKER CHEMIE AG 277
12.2.15 GEON PERFORMANCE SOLUTIONS LLC 278

13 RESEARCH METHODOLOGY 279
13.1 RESEARCH DATA 279
13.1.1 SECONDARY DATA 280
13.1.1.1 Key data from secondary sources 280
13.1.2 PRIMARY DATA 280
13.1.2.1 Key data from primary sources 281
13.1.2.2 Key industry insights 281
13.2 MARKET SIZE ESTIMATION 282
13.3 BASE NUMBER CALCULATION 284
13.4 MARKET FORECAST APPROACH 284
13.5 DATA TRIANGULATION 285
13.6 FACTOR ANALYSIS 287
13.7 RESEARCH ASSUMPTIONS 287
13.8 RESEARCH LIMITATIONS AND RISK ASSESSMENT 288

14 APPENDIX 289
14.1 DISCUSSION GUIDE 289
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 291
14.3 CUSTOMIZATION OPTIONS 293
14.4 RELATED REPORTS 293
14.5 AUTHOR DETAILS 294

ページTOPに戻る

List of Tables/Graphs

FIGURE 1 MEDICAL PLASTICS MARKET SEGMENTATION AND REGIONAL SCOPE 27.
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 32.
FIGURE 3 MEDICAL PLASTICS MARKET, 2025–2031 32.
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL.
PLASTICS MARKET (2021–2025) 33.
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL PLASTICS MARKET 34.
FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN MEDICAL PLASTICS MARKET, 2026–2031 35.
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 36.
FIGURE 8 HIGH DEMAND FOR MEDICAL DISPOSABLES TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 37.
FIGURE 9 CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 38.
FIGURE 10 PP SEGMENT ACCOUNTED FOR LARGEST SHARE OF MEDICAL.
PLASTICS MARKET IN 2025 39.
FIGURE 11 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 39.
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN.
MEDICAL PLASTICS MARKET 41.
FIGURE 13 MEDICAL PLASTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 52.
FIGURE 14 MEDICAL PLASTICS MARKET: VALUE CHAIN ANALYSIS 57.
FIGURE 15 MEDICAL PLASTICS MARKET: ECOSYSTEM ANALYSIS 59.
FIGURE 16 AVERAGE SELLING PRICE TREND OF MEDICAL PLASTICS, BY REGION (2023-2025) 61.
FIGURE 17 IMPORT DATA FOR HS CODE 3926-COMPLIANT PRODUCTS,.
BY KEY COUNTRIES, 2021–2025 69.
FIGURE 18 EXPORT DATA RELATED TO HS CODE 3936-COMPLIANT PRODUCTS,.
BY KEY COUNTRIES, 2021–2025 70.
FIGURE 19 TRENDS/DISRUPTIONS INFLUENCING MEDICAL PLASTICS MARKET GROWTH 71.
FIGURE 20 INVESTMENT AND FUNDING SCENARIO, 2020-2025 72.
FIGURE 21 LIST OF MAJOR PATENTS FOR MEDICAL PLASTICS, 2016–2025 79.
FIGURE 22 PATENT ANALYSIS, BY LEGAL STATUS 80.
FIGURE 23 TOP JURISDICTION, BY DOCUMENT 80.
FIGURE 24 MEDICAL PLASTICS MARKET: DECISION-MAKING FACTORS 95.
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS 96.
FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 97.
FIGURE 27 ADOPTION BARRIERS & INTERNAL CHALLENGES 98.
FIGURE 28 ENGINEERING AND HIGH PERFORMANCE PLASTICS TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 104.
FIGURE 29 MEDICAL DISPOSABLES TO BE LARGEST APPLICATION IN MEDICAL PLASTICS MARKET DURING FORECAST PERIOD 112.
FIGURE 30 INDIA TO REGISTER HIGHEST CAGR IN MEDICAL PLASTICS MARKET DURING FORECAST PERIOD 119.
FIGURE 31 NORTH AMERICA: MEDICAL PLASTICS MARKET SNAPSHOT 121.
FIGURE 32 ASIA PACIFIC: MEDICAL PLASTICS MARKET SNAPSHOT 151.
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL PLASTICS MARKET, 2021–2025 198.
FIGURE 34 MEDICAL PLASTICS MARKET SHARE ANALYSIS, 2025 199.
FIGURE 35 MEDICAL PLASTICS MARKET: PRODUCT COMPARATIVE ANALYSIS 202.
FIGURE 36 MEDICAL PLASTICS MARKET: COMPANY EVALUATION MATRIX.
(KEY PLAYERS), 2025 204.
FIGURE 37 MEDICAL PLASTICS MARKET: COMPANY FOOTPRINT 205.
FIGURE 38 MEDICAL PLASTICS MARKET: COMPANY EVALUATION MATRIX.
(STARTUPS/SMES), 2025 208.
FIGURE 39 EV/EBITDA OF KEY MANUFACTURERS IN MEDICAL PLASTICS MARKET 212.
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY MANUFACTURERS IN MEDICAL PLASTICS MARKET 213.
FIGURE 41 ENTERPRISE VALUATION OF KEY PLAYERS IN MEDICAL PLASTICS MARKET (2025) 213.
FIGURE 42 BASF: COMPANY SNAPSHOT 218.
FIGURE 43 CELANESE CORPORATION: COMPANY SNAPSHOT 223.
FIGURE 44 SABIC: COMPANY SNAPSHOT 228.
FIGURE 45 COVESTRO AG: COMPANY SNAPSHOT 234.
FIGURE 46 SYENSQO: COMPANY SNAPSHOT 239.
FIGURE 47 EVONIK INDUSTRIES: COMPANY SNAPSHOT 243.
FIGURE 48 ARKEMA: COMPANY SNAPSHOT 248.
FIGURE 49 DOW: COMPANY SNAPSHOT 261.
FIGURE 50 MEDICAL PLASTICS MARKET: RESEARCH DESIGN 279.
FIGURE 51 BREAKDOWN OF INTERVIEWS WITH EXPERTS 282.
FIGURE 52 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 283.
FIGURE 53 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 283.
FIGURE 54 MEDICAL PLASTICS MARKET: APPROACH 1 284.
FIGURE 55 MEDICAL PLASTICS MARKET: APPROACH 2 284.
FIGURE 56 MEDICAL PLASTICS MARKET: DATA TRIANGULATION 286.
TABLE 1 CAPITAL HEALTHCARE EXPENDITURE, 2020–2023 (USD MILLION) 45.
TABLE 2 HEALTHCARE SPENDING, 2023 (USD MILLION) 46.
TABLE 3 MEDICAL PLASTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 53.
TABLE 4 MEDICAL PLASTICS MARKET: ROLES OF COMPANIES IN ECOSYSTEM 60.
TABLE 5 GDP TRENDS AND FORECAST OF MAJOR ECONOMIES,.
2023–2030 (USD BILLION, CURRENT PRICES) 62.
TABLE 6 U.S. NATIONAL HEALTH EXPENDITURE (NHE) TRENDS, 2022–2033 64.
TABLE 7 US-ADJUSTED RECIPROCAL TARIFF RATES 65.
TABLE 8 IMPORT SCENARIO FOR HS CODE 3926-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 69.
TABLE 9 EXPORT SCENARIO FOR HS CODE 3926-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 70.
TABLE 10 MEDICAL PLASTICS MARKET: CONFERENCES & EVENTS, 2026–2027 74.
TABLE 11 TOP USE CASES AND MARKET POTENTIAL 85.
TABLE 12 BEST PRACTICES: NOTABLE INDUSTRY PRACTICES BY LEADING COMPANIES 85.
TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 87.
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 89.
TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 90.
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 90.
TABLE 17 GLOBAL STANDARDS IN MEDICAL PLASTICS MARKET 92.
TABLE 18 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN MEDICAL PLASTICS MARKET 93.
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS (%) 96.
TABLE 20 KEY BUYING CRITERIA FOR KEY APPLICATIONS 97.
TABLE 21 MEDICAL PLASTICS MARKET: UNMET NEEDS IN KEY END-USE INDUSTRIES 99.
TABLE 22 MEDICAL PLASTICS MARKET, BY TYPE, 2023–2025 (USD MILLION) 105.
TABLE 23 MEDICAL PLASTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 105.
TABLE 24 MEDICAL PLASTICS MARKET, BY TYPE, 2023–2025 (KILOTON) 106.
TABLE 25 MEDICAL PLASTICS MARKET, BY TYPE, 2026–2031 (KILOTON) 106.
TABLE 26 MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (USD MILLION) 112.
TABLE 27 MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 113.
TABLE 28 MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 113.
TABLE 29 MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 113.
TABLE 30 MEDICAL PLASTICS MARKET, BY REGION, 2023–2025 (USD MILLION) 119.
TABLE 31 MEDICAL PLASTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 119.
TABLE 32 MEDICAL PLASTICS MARKET, BY REGION, 2023–2025 (KILOTON) 120.
TABLE 33 MEDICAL PLASTICS MARKET, BY REGION, 2026–2031 (KILOTON) 120.
TABLE 34 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2023–2025 (USD MILLION) 121.
TABLE 35 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2026–2031 (USD MILLION) 122.
TABLE 36 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2023–2025 (KILOTON) 122.
TABLE 37 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2026–2031 (KILOTON) 122.
TABLE 38 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE,.
2023–2025 (USD MILLION) 123.
TABLE 39 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE,.
2026–2031 (USD MILLION) 123.
TABLE 40 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2023–2025 (KILOTON) 124.
TABLE 41 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2026–2031 (KILOTON) 124.
TABLE 42 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 125.
TABLE 43 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 125.
TABLE 44 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 126.
TABLE 45 NORTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 126.
TABLE 46 US: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (USD MILLION) 127.
TABLE 47 US: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 127.
TABLE 48 US: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 128.
TABLE 49 US: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 128.
TABLE 50 CANADA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 129.
TABLE 51 CANADA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 129.
TABLE 52 CANADA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 130.
TABLE 53 CANADA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 130.
TABLE 54 MEXICO: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 131.
TABLE 55 MEXICO: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 132.
TABLE 56 MEXICO: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 132.
TABLE 57 MEXICO: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 132.
TABLE 58 EUROPE: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023–2025 (USD MILLION) 133.
TABLE 59 EUROPE: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 134.
TABLE 60 EUROPE: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023–2025 (KILOTON) 134.
TABLE 61 EUROPE: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026–2031 (KILOTON) 134.
TABLE 62 EUROPE: MEDICAL PLASTICS MARKET, BY TYPE, 2023–2025 (USD MILLION) 135.
TABLE 63 EUROPE: MEDICAL PLASTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 135.
TABLE 64 EUROPE: MEDICAL PLASTICS MARKET, BY TYPE, 2023–2025 (KILOTON) 135.
TABLE 65 EUROPE: MEDICAL PLASTICS MARKET, BY TYPE, 2026–2031 (KILOTON) 136.
TABLE 66 EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 137.
TABLE 67 EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 137.
TABLE 68 EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 137.
TABLE 69 EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 138.
TABLE 70 GERMANY: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 139.
TABLE 71 GERMANY: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 139.
TABLE 72 GERMANY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 139.
TABLE 73 GERMANY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 140.
TABLE 74 FRANCE: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 141.
TABLE 75 FRANCE: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 141.
TABLE 76 FRANCE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 141.
TABLE 77 FRANCE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 142.
TABLE 78 SPAIN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (USD MILLION) 143.
TABLE 79 SPAIN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 143.
TABLE 80 SPAIN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 143.
TABLE 81 SPAIN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 144.
TABLE 82 UK: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (USD MILLION) 145.
TABLE 83 UK: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 145.
TABLE 84 UK: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 145.
TABLE 85 UK: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 146.
TABLE 86 ITALY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (USD MILLION) 147.
TABLE 87 ITALY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 147.
TABLE 88 ITALY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 147.
TABLE 89 ITALY: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 148.
TABLE 90 REST OF EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 149.
TABLE 91 REST OF EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 149.
TABLE 92 REST OF EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 149.
TABLE 93 REST OF EUROPE: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 150.
TABLE 94 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2023–2025 (USD MILLION) 151.
TABLE 95 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2026–2031 (USD MILLION) 152.
TABLE 96 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY COUNTRY, 2023–2025 (KILOTON) 152.
TABLE 97 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY COUNTRY, 2026–2031 (KILOTON) 152.
TABLE 98 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY TYPE, 2023–2025 (USD MILLION) 153.
TABLE 99 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY TYPE, 2026–2031 (USD MILLION) 153.
TABLE 100 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY TYPE, 2023–2025 (KILOTON) 153.
TABLE 101 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY TYPE, 2026–2031 (KILOTON) 154.
TABLE 102 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 155.
TABLE 103 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 155.
TABLE 104 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 155.
TABLE 105 ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 156.
TABLE 106 CHINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (USD MILLION) 157.
TABLE 107 CHINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 157.
TABLE 108 CHINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 157.
TABLE 109 CHINA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 158.
TABLE 110 JAPAN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (USD MILLION) 159.
TABLE 111 JAPAN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 159.
TABLE 112 JAPAN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 159.
TABLE 113 JAPAN: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 160.
TABLE 114 INDIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (USD MILLION) 161.
TABLE 115 INDIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 161.
TABLE 116 INDIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 162.
TABLE 117 INDIA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 162.
TABLE 118 SOUTH KOREA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 163.
TABLE 119 SOUTH KOREA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 163.
TABLE 120 SOUTH KOREA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 164.
TABLE 121 SOUTH KOREA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 164.
TABLE 122 REST OF ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 165.
TABLE 123 REST OF ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 165.
TABLE 124 REST OF ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 166.
TABLE 125 REST OF ASIA PACIFIC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 166.
TABLE 126 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2023–2025 (USD MILLION) 167.
TABLE 127 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2026–2031 (USD MILLION) 167.
TABLE 128 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2023–2025 (KILOTON) 168.
TABLE 129 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2026–2031 (KILOTON) 168.
TABLE 130 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY TYPE,.
2023–2025 (USD MILLION) 169.
TABLE 131 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY TYPE,.
2026–2031 (USD MILLION) 169.
TABLE 132 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY TYPE,.
2023–2025 (KILOTON) 170.
TABLE 133 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY TYPE,.
2026–2031 (KILOTON) 170.
TABLE 134 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 171.
TABLE 135 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 171.
TABLE 136 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 171.
TABLE 137 MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 172.
TABLE 138 SAUDI ARABIA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 174.
TABLE 139 SAUDI ARABIA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 174.
TABLE 140 SAUDI ARABIA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 174.
TABLE 141 SAUDI ARABIA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 175.
TABLE 142 UAE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (USD MILLION) 176.
TABLE 143 UAE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 176.
TABLE 144 UAE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 176.
TABLE 145 UAE: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 177.
TABLE 146 REST OF GCC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 178.
TABLE 147 REST OF GCC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 178.
TABLE 148 REST OF GCC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 178.
TABLE 149 REST OF GCC: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 179.
TABLE 150 SOUTH AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 180.
TABLE 151 SOUTH AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 180.
TABLE 152 SOUTH AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 180.
TABLE 153 SOUTH AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 181.
TABLE 154 REST OF MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (USD MILLION) 182.
TABLE 155 REST OF MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 182.
TABLE 156 REST OF MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 183.
TABLE 157 REST OF MIDDLE EAST & AFRICA: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 183.
TABLE 158 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2023–2025 (USD MILLION) 184.
TABLE 159 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2026–2031 (USD MILLION) 184.
TABLE 160 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2023–2025 (KILOTON) 184.
TABLE 161 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY COUNTRY,.
2026–2031 (KILOTON) 185.
TABLE 162 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE,.
2023–2025 (USD MILLION) 185.
TABLE 163 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE,.
2026–2031 (USD MILLION) 186.
TABLE 164 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2023–2025 (KILOTON) 186.
TABLE 165 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY TYPE, 2026–2031 (KILOTON) 187.
TABLE 166 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 187.
TABLE 167 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 188.
TABLE 168 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 188.
TABLE 169 SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 188.
TABLE 170 BRAZIL: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 189.
TABLE 171 BRAZIL: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 190.
TABLE 172 BRAZIL: MEDICAL PLASTICS MARKET, BY APPLICATION, 2023–2025 (KILOTON) 190.
TABLE 173 BRAZIL: MEDICAL PLASTICS MARKET, BY APPLICATION, 2026–2031 (KILOTON) 190.
TABLE 174 ARGENTINA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 192.
TABLE 175 ARGENTINA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 192.
TABLE 176 ARGENTINA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 192.
TABLE 177 ARGENTINA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 193.
TABLE 178 REST OF SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (USD MILLION) 194.
TABLE 179 REST OF SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 194.
TABLE 180 REST OF SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2023–2025 (KILOTON) 194.
TABLE 181 REST OF SOUTH AMERICA: MEDICAL PLASTICS MARKET, BY APPLICATION,.
2026–2031 (KILOTON) 195.
TABLE 182 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN MEDICAL PLASTICS MARKET, JANUARY 2021–JUNE 2026 197.
TABLE 183 MEDICAL PLASTICS MARKET: DEGREE OF COMPETITION, 2025 199.
TABLE 184 MEDICAL PLASTICS MARKET: REGION FOOTPRINT 205.
TABLE 185 MEDICAL PLASTICS MARKET: TYPE FOOTPRINT 206.
TABLE 186 MEDICAL PLASTICS MARKET: APPLICATION FOOTPRINT 207.
TABLE 187 MEDICAL PLASTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 209.
TABLE 188 MEDICAL PLASTICS MARKET: COMPETITIVE BENCHMARKING.
OF KEY STARTUPS/SMES 211.
TABLE 189 MEDICAL PLASTICS MARKET: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2026 214.
TABLE 190 MEDICAL PLASTICS MARKET: DEALS, JANUARY 2020–JUNE 2026 215.
TABLE 191 MEDICAL PLASTICS MARKET: EXPANSIONS, JANUARY 2020–JUNE 2026 216.
TABLE 192 BASF: COMPANY OVERVIEW 217.
TABLE 193 BASF: PRODUCTS/SOLUTIONS/SERVICES OFFERED 218.
TABLE 194 BASF: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 219.
TABLE 195 BASF: EXPANSIONS, JANUARY 2021–JUNE 2026 220.
TABLE 196 CELANESE CORPORATION: COMPANY OVERVIEW 222.
TABLE 197 CELANESE CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 223.
TABLE 198 CELANESE CORPORATION: DEALS, JANUARY 2021–JUNE 2026 225.
TABLE 199 SABIC: COMPANY OVERVIEW 227.
TABLE 200 SABIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 228.
TABLE 201 SABIC: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 230.
TABLE 202 SABIC: DEALS, JANUARY 2021–JUNE 2026 231.
TABLE 203 COVESTRO AG: COMPANY OVERVIEW 233.
TABLE 204 COVESTRO AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 234.
TABLE 205 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 236.
TABLE 206 SYENSQO: COMPANY OVERVIEW 238.
TABLE 207 SYENSQO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 239.
TABLE 208 SYENSQO: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 240.
TABLE 209 SYENSQO: DEALS, JANUARY 2021–JUNE 2026 241.
TABLE 210 EVONIK INDUSTRIES: COMPANY OVERVIEW 243.
TABLE 211 EVONIK INDUSTRIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 244.
TABLE 212 EVONIK INDUSTRIES: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 245.
TABLE 213 EVONIK INDUSTRIES: EXPANSIONS, JANUARY 2021–JUNE 2026 245.
TABLE 214 ARKEMA: COMPANY OVERVIEW 247.
TABLE 215 ARKEMA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 248.
TABLE 216 ARKEMA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 249.
TABLE 217 ARKEMA: DEALS, JANUARY 2021–JUNE 2026 250.
TABLE 218 LUBRIZOL: COMPANY OVERVIEW 251.
TABLE 219 LUBRIZOL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252.
TABLE 220 LUBRIZOL: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 254.
TABLE 221 LUBRIZOL: DEALS, JANUARY 2021–JUNE 2026 254.
TABLE 222 LUBRIZOL: EXPANSIONS, JANUARY 2021–JUNE 2026 255.
TABLE 223 ENSINGER: COMPANY OVERVIEW 257.
TABLE 224 ENSINGER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 257.
TABLE 225 DOW: COMPANY OVERVIEW 260.
TABLE 226 DOW: PRODUCTS/SOLUTIONS/SERVICES OFFERED 261.
TABLE 227 DOW: DEALS, JANUARY 2021–JUNE 2026 262.
TABLE 228 TRINSEO: COMPANY OVERVIEW 264.
TABLE 229 BIOMERICS: COMPANY OVERVIEW 265.
TABLE 230 ENVALIOR: COMPANY OVERVIEW 266.
TABLE 231 EASTMAN CHEMICAL COMPANY: COMPANY OVERVIEW 267.
TABLE 232 INVIBIO LTD.: COMPANY OVERVIEW 268.
TABLE 233 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.: COMPANY OVERVIEW 269.
TABLE 234 MITSUBISHI CHEMICAL GROUP: COMPANY OVERVIEW 270.
TABLE 235 AVIENT CORPORATION: COMPANY OVERVIEW 271.
TABLE 236 RÖCHLING SE & CO. KG: COMPANY OVERVIEW 272.
TABLE 237 RTP COMPANY: COMPANY OVERVIEW 273.
TABLE 238 SAINT-GOBAIN: COMPANY OVERVIEW 274.
TABLE 239 TEKNI-PLEX, INC.: COMPANY OVERVIEW 275.
TABLE 240 TEKNOR APEX COMPANY: COMPANY OVERVIEW 276.
TABLE 241 WACKER CHEMIE AG: COMPANY OVERVIEW 277.
TABLE 242 GEON PERFORMANCE SOLUTIONS LLC: COMPANY OVERVIEW 278.